Dr. Tammy Saah, M.D. is a board-certified psychiatrist through the American Board of Psychiatry and Neurology, with specialized expertise in Treatment-Resistant Depression (TRD), Complex Post-Traumatic Stress Disorder (CPTSD), and ketamine-assisted therapies.

A Bay Area native, Dr. Saah earned her B.A. in Psychobiology from the University of California, Santa Cruz and a M.A. in Neurophysiology from San Jose State University before completing her medical degree at the American University of Beirut. She went on to train at Emory University’s Department of Psychiatry and Behavioral Sciences, where she completed her residency and served as Chief Resident (2013–2014).  At Emory, Dr. Saah became the department’s first-ever fellow in Treatment-Resistant Depression, playing a central role in establishing the Emory Healthcare TRD Clinic—an innovative research program for patients with mood disorders who had not responded to standard treatments. This experience cemented her commitment to advancing care for complex psychiatric conditions.

Her clinical work focuses on advanced psychopharmacology, trauma psychiatry, and novel therapeutics, with extensive experience in the use of ketamine therapy for chronic and treatment-resistant illness. She is an active member of the American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP3) and is recognized as a leading provider in the field.  

Dr. Saah also collaborates closely with a trusted network of psychiatrists and psychotherapists across California, offering integrated, multidisciplinary treatment for CPTSD and related conditions. Through these partnerships, she is committed to guiding patients toward relief from the lasting effects of trauma and restoring balance, resilience, and peace.